Support your adolescent‘s weight-management goals
If your child is 12 to 17 years old and struggles with obesity, Wegovy® pen may help them manage their weight.
Obesity in children
According to the Centers for Disease Control and Prevention (CDC), obesity is a disease that affects people of all ages, including adolescents.
Understanding body mass index (BMI)
BMI is a calculated measure of weight relative to height. BMI is used as a medical screening tool for assessing obesity and overweight. Obesity in children is defined as a BMI at or above the 95th percentile on sex- and age-specific growth charts.
For more information, see the FAQs.
Weight management with Wegovy® pen in adolescents
In a medical study: 201 adolescents aged 12 to 17 years old who had obesity with a BMI at or above the 95th percentile (according to sex-and age-specific growth charts) took part in the 68 week-trial. The adolescents received either Wegovy® pen or placebo (not on medicine). Everyone received lifestyle counseling about healthy nutrition and physical activity.
Adolescents who
used Wegovy® pen
had on average a
16.1%
BMI reduction
37.7 starting BMI
Adolescents who
used placebo
had on average a
0.6%
BMI increase
35.7 starting BMI
In both groups,
10% of participants discontinued the study.
In the medical study, people who stopped taking Wegovy® generally regained weight.
Once-Weekly Injection
Get to know Wegovy® pen
Wegovy® comes in a prefilled pen and is used once a week. Use exactly as your healthcare professional has shown you.
Want more of the details? Grab the guide!
5 steps for using your Wegovy® pen
- Get your supplies together in one place: you‘ll need your Wegovy® pen, 1 alcohol swab or soap and water, 1 gauze pad or cotton ball, and an FDA-approved sharps container for the used Wegovy® pen
- Wash your hands
- Check your Wegovy® pen
Do not use the pen if:
- It appears to have been used
- Any part appears broken
- The Wegovy® medicine is not clear and colorless through the pen window (air bubbles are normal)
- The expiration date (EXP) has passed
Your healthcare professional can help you choose the injection site that is best for you.
- You may inject into your upper leg (front of the thigh), lower stomach (keep 2 inches away from your belly button), or upper arm—but make sure you can clearly see the pen window while injecting
- Do not inject into an area where the skin is tender, bruised, red, or hard. You should also avoid injecting into areas with scars or stretch marks
- You may inject into the same body area each week, but not in the exact same spot each time
Before taking Wegovy®, clean your chosen injection site with an alcohol swab or soap and water.
Do not touch the injection site after cleaning. Allow the skin to dry before injecting.
- Pull the pen cap straight off your pen
- The needle is hidden, so you don’t have to see or handle it
- Just because you can’t see it, doesn't mean it isn’t there! Be careful not to push down on the needle cover to avoid needlestick injuries
Push the pen firmly against your skin and keep applying pressure.
You’ll know your injection has started when the yellow bar starts moving. If you don’t see it moving, press the pen more firmly against your skin.
The injection should take about 5-10 seconds
Don’t stop after 2 clicks. You will hear 2 clicks during the injection
After injecting your Wegovy® dose, do not throw away the pen in your household trash or recycling bin. Instead, use either
- An FDA-cleared sharps disposal container
- A sturdy household container with a tight-fitting lid, like a heavy-duty plastic container. Make sure to write on the container that there is hazardous waste inside.
You can request a complimentary sharps disposal container from Novo Nordisk®. Learn more
How you dispose of your sharps container is also important. Follow the guidelines for where you live. To find a sharps disposal location near you, visit safeneedledisposal.org.
Learn more in the Wegovy® Medication Guide.
What if blood appears after the injection?
If blood appears at the injection site, press lightly with a gauze pad or cotton ball.
Wegovy® pen dosing for adolescents
The starting dose of Wegovy® is 0.25 mg once weekly, and your adolescent will gradually increase their dose every 4 weeks until they reach their maintenance dose of either 1.7 mg or 2.4 mg. Gradually increasing the dose helps their body get used to the medicine. Work with your adolescent's health care professional to determine which dose is right for them.
Important instructions for using Wegovy® pen
Important tips for stepping up to the next dose
Check in with your adolescent’s healthcare professional:
- When your child is stepping up their dose
- To track their progress and see what‘s working for them
- If they experience any bothersome side effects or lingering side effects
If your adolescent needs to change the day day of the week they take Wegovy®, they may do so as long as their last dose was given 2 or more days before.
Missed dose?
If things don‘t go according to plan, your adolescent can always get back on track.
If their NEXT scheduled dose is:
- Less than 2 days (48 hours) away, do not take the dose. Instead, wait to take the next dose on the regularly scheduled day
- More than 2 days (48 hours) away, take the missed dose as soon as possible
- If it‘s been 2 or more weeks (14 days) since their last dose, you can either ensure they take the next dose on the regularly scheduled day or talk to their healthcare professional about how to restart or adjust treatment
Troubleshooting problems with the pen
- If your adolescent has problems injecting, they can change to a more firm injection site, such as the upper leg or upper arm. They could also consider standing up while injecting into the lower stomach (abdomen)
- If medicine appears on the skin or squirts from the needle, make sure the next time your adolescent injects, they keep applying pressure until the yellow bar has stopped moving. Then, they can lift the pen slowly from their skin
What your adolescent might expect
The most common side effects of Wegovy® may include:
- Nausea
- Diarrhea
- Vomiting
- Constipation
- Stomach (abdomen) pain
- Headache
- Tiredness (fatigue)
- Upset stomach
- Dizziness
- Feeling bloated
- Belching
- Low blood sugar in people
with type 2 diabetes
- Gas
- Stomach flu
- Heartburn
- Runny nose or sore throat
Pay attention to how your adolescent is feeling and talk with their healthcare professional about any side effects they experience.
For adolescents aged 12 to 17 years, the side effects of Wegovy® were generally similar to those seen in adults. However, in the adolescent study, adolescents had a higher chance of experiencing gallstones, gallbladder inflammation, low blood pressure, rash, and hives compared with studies of adults treated with Wegovy®.
Wegovy® and type 2 diabetes
There is not enough information to know if Wegovy® raises the risk of low blood sugar in adolescents with type 2 diabetes, like what is seen in adults. If your adolescent has type 2 diabetes and is prescribed Wegovy® for obesity, talk with their healthcare professional to understand the risk of low blood sugar as well as how to recognize the signs and symptoms.
Their healthcare professional will check their blood sugar prior to starting Wegovy® and throughout treatment. As they’re getting started with Wegovy®, their healthcare professional might lower the doses of other diabetes medicines they may be taking (like sulfonylureas or insulin) to lessen the chance of low blood sugar.
Talk it out with your adolescent’s care team
Let your adolescent’s care team know about any side effect that bothers them or doesn’t go away. Everyone is different, so your adolescent‘s healthcare professional can help you determine the best course of action. If your adolescent experiences nausea, talk with their healthcare professional for guidance, which may include some of these general tips.
Here are a few suggestions their healthcare professional may recommend:
THINGS THAT MAY HELP:
- Bland, low-fat foods, like crackers, toast, and rice
- Foods that contain water, like soups and gelatin
WHAT THEY MAY WANT TO AVOID:
- Lying down after eating
- Eating greasy foods
WHAT THEY CAN DO:
- Intentionally eat more slowly
- Get fresh air outside
- Talk frequently with their healthcare professional
- Read the Wegovy® Medication Guide
Your adolescent’s healthcare professional is always the best person to go to for answers about side effects of Wegovy®, stepping up your adolescent’s dose, and beyond.
You can also find details in the Wegovy® Medication Guide or call the Wegovy® Navigation Line at 1-833-4-WEGOVY (1-833-493-4689) Monday-Friday between 9:00 AM and 6:00 PM ET.
If your adolescent is ready to start Wegovy®, check your options for cost and coverage with our easy-to-use tool.
FAQs
What to expect, side effects, and more
Wegovy® works by mimicking a hormone called GLP-1 (glucagon-like peptide-1), which targets areas of the brain involved in regulating appetite and food intake. This can help your adolescent eat less, which can lead to weight loss.
When combined with a reduced-calorie diet and increased physical activity, a 68-week medical study of 201 adolescents aged 12 to 17 years with obesity, showed that adolescents using Wegovy® pen lowered their body mass index (BMI) by 16.1% while those using placebo (an inactive injection) raised their BMI by 0.6%.
You should discuss with your healthcare professional the BMI of your adolescent to determine if they are suited for Wegovy®.
Results are from a 68-week medical study of 201 adolescent patients aged 12 to 17 years with a BMI in the 95th percentile or higher (according to sex- and age-specific growth charts) that compared Wegovy® with placebo. Both groups received counseling on healthy nutrition and physical activity for weight loss. The average starting BMI for people using Wegovy® was 37.7 kg/m2. The average starting BMI for people using placebo was 35.7 kg/m2.
Because of adolescents‘ weight and height change during growth and development, BMI is represented as a percentile using age- and sex-specific growth charts. The percentile tells us the adolescent’s BMI in relation to peers of the same age and sex. For example, if a 15-year-old boy has a BMI in the 50th percentile, his BMI is higher than the BMIs of 50% of 15-year-old boys. Obesity is defined as a BMI at or above the 95th percentile at the time the growth charts were developed.
Chronic diseases like obesity usually require long-term management. Your adolescent’s healthcare professional can create a plan tailored to their weight-management goals. Your adolescent should visit their healthcare professional to review their progress and renew their prescription.
At the end of the adolescent medical study, patients stopped Wegovy® and were observed for 7 weeks on lifestyle therapy only. After stopping Wegovy®, weight regain was observed.
The healthcare professional should teach you and your adolescent how to inject Wegovy® before they take it for the first time. If either of you have questions or do not understand the instructions, ask a healthcare professional. See the full Instructions for Use that come with the Medication Guide for detailed information about the right way to use the Wegovy® pen.
Wegovy® is injected under the skin (this is called a subcutaneous injection) in the upper leg (front of the thigh), lower stomach (keep 2 inches away from belly button), or upper arm as instructed by a healthcare professional. Wegovy® is not to be injected into a vein or muscle. See the full Instructions for Use that come with the Medication Guide for detailed information about the right way to use the Wegovy® pen.
Adverse reactions with Wegovy® treatment in adolescent patients aged 12 to 17 years were similar to those reported in adults. However, adolescent patients aged 12 years and older treated with Wegovy® in a study had a higher incidence of gallstones, gallbladder inflammation, low blood pressure, rash, and hives compared with studies of adults treated with Wegovy®.
The most common side effects of Wegovy® may include: nausea, diarrhea, vomiting, constipation, stomach (abdomen) pain, headache, tiredness (fatigue), upset stomach, dizziness, feeling bloated, belching, low blood sugar in people with type 2 diabetes, gas, stomach flu, heartburn, and runny nose or sore throat.
If your adolescent experiences any side effects, tell their healthcare professional.
The free WeGoTogether® personalized support program is designed for patients 18 years or older; however, as a caregiver you may access the Wegovy® Navigation Line at 1-833-4-WEGOVY if you would like more information.
Important Safety Information
What is the most important information I should know about Wegovy®?
Wegovy® may cause serious side effects, including:
- Possible thyroid tumors, including cancer. Tell your healthcare provider if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. These may be symptoms of thyroid cancer. In studies with rodents, Wegovy® and other medicines that work like Wegovy® caused thyroid tumors, including thyroid cancer. It is not known if Wegovy® will cause thyroid tumors or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in people
- Do not use Wegovy® if you or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC) or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
Do not use Wegovy® if:
- you or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC) or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
- you have had a serious allergic reaction to semaglutide or any of the ingredients in Wegovy® injection or Wegovy® tablets. See symptoms of serious allergic reaction in “What are the possible side effects of Wegovy®?”
Before using Wegovy®, tell your healthcare provider if you have any other medical conditions, including if you:
- have or have had problems with your pancreas or kidneys
- have type 2 diabetes and a history of diabetic retinopathy
- have or have had depression, suicidal thoughts, or mental health issues
- are scheduled to have surgery or other procedures that use anesthesia or deep sleepiness (deep sedation)
- are pregnant or plan to become pregnant. Wegovy® may harm your unborn baby. You should stop using Wegovy® 2 months before you plan to become pregnant
- are breastfeeding or plan to breastfeed. Breastfeeding is not recommended during treatment with Wegovy® tablets. It is not known if Wegovy® when received through an injection passes into your breast milk
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Wegovy® may affect the way some medicines work and some medicines may affect the way Wegovy® works. Tell your healthcare provider if you are taking other medicines to treat diabetes, including sulfonylureas or insulin. Wegovy® slows stomach emptying and can affect medicines that need to pass through the stomach quickly.
What are the possible side effects of Wegovy®?
Wegovy® may cause serious side effects, including:
- inflammation of your pancreas (pancreatitis). Stop using Wegovy® and call your healthcare provider right away if you have severe pain in your stomach area (abdomen) that will not go away, with or without nausea or vomiting. Sometimes you may feel the pain from your abdomen to your back
- gallbladder problems. Wegovy® may cause gallbladder problems, including gallstones. Some gallstones may need surgery. Call your healthcare provider if you have symptoms, such as pain in your upper stomach (abdomen), fever, yellowing of the skin or eyes (jaundice), or clay-colored stools
- increased risk of low blood sugar (hypoglycemia), especially those who also take medicines for diabetes such as insulin or sulfonylureas. This can be a serious side effect. Talk to your healthcare provider about how to recognize and treat low blood sugar and check your blood sugar before you start and while you take Wegovy®. Signs and symptoms of low blood sugar may include dizziness or light-headedness, blurred vision, anxiety, irritability or mood changes, sweating, slurred speech, hunger, confusion or drowsiness, shakiness, weakness, headache, fast heartbeat, or feeling jittery
- dehydration leading to kidney problems. Diarrhea, nausea, and vomiting may cause a loss of fluids (dehydration), which may cause kidney problems. It is important for you to drink fluids to help reduce your chance of dehydration. Tell your healthcare provider right away if you have nausea, vomiting, or diarrhea that does not go away
- severe stomach problems. Stomach problems, sometimes severe, have been reported in people who use Wegovy®. Tell your healthcare provider if you have stomach problems that are severe or will not go away
- serious allergic reactions. Stop using Wegovy® and get medical help right away, if you have any symptoms of a serious allergic reaction, including swelling of your face, lips, tongue, or throat; problems breathing or swallowing; severe rash or itching; fainting or feeling dizzy; or very rapid heartbeat
- change in vision in people with type 2 diabetes. Tell your healthcare provider if you have changes in vision during treatment with Wegovy®
- increased heart rate. Wegovy® can increase your heart rate while you are at rest. Tell your healthcare provider if you feel your heart racing or pounding in your chest and it lasts for several minutes
- depression or thoughts of suicide. You should pay attention to any mental changes, especially sudden changes in your mood, behaviors, thoughts, or feelings. Call your healthcare provider right away if you have any mental changes that are new, worse, or worry you
- food or liquid getting into the lungs during surgery or other procedures that use anesthesia or deep sleepiness (deep sedation). Wegovy® may increase the chance of food getting into your lungs during surgery or other procedures. Tell all your healthcare providers that you are taking Wegovy® before you are scheduled to have surgery or other procedures
The most common side effects of Wegovy® may include: nausea, diarrhea, vomiting, constipation, stomach (abdomen) pain, headache, tiredness (fatigue), upset stomach, dizziness, feeling bloated, belching, low blood sugar in people with type 2 diabetes, gas, stomach flu, heartburn, and runny nose or sore throat.
Please see Prescribing Information and Medication Guide for Wegovy®.
Wegovy® is a prescription medication.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
This site is intended for US patients only.
What is Wegovy®?
Wegovy® (semaglutide) injection 1.7 mg or 2.4 mg and Wegovy® (semaglutide) tablets 25 mg are prescription medicines used with a reduced calorie diet and increased physical activity to:
- reduce the risk of major cardiovascular events such as death, heart attack, or stroke in adults with known heart disease and with either obesity or overweight.
- help adults with obesity, or some adults with excess weight (overweight) who also have weight-related medical problems to lose weight and keep the weight off.
Wegovy® (semaglutide) injection 1.7 mg or 2.4 mg is used with a reduced-calorie diet and increased physical activity to help children 12 years and older with obesity to lose weight and keep the weight off
Wegovy® contains semaglutide and should not be used with other semaglutide-containing products or other GLP-1 receptor agonist medicines.
It is not known if Wegovy® injection is safe and effective:
- to reduce the risk of major cardiovascular events (death, heart attack, or stroke) in people under 18 years
- to help children under 12 years of age lose weight and keep the weight off
It is not known if Wegovy® tablets are safe and effective for use in people under 18 years of age.
Wegovy® (semaglutide) injection 1.7 mg or 2.4 mg and Wegovy® (semaglutide) tablets 25 mg are prescription medicines used with a reduced calorie diet and increased physical activity to:
- reduce the risk of major cardiovascular events such as death, heart attack, or stroke in adults with known heart disease and with either obesity or overweight.
- help adults with obesity, or some adults with excess weight (overweight) who also have weight-related medical problems to lose weight and keep the weight off.
Wegovy® (semaglutide) injection 1.7 mg or 2.4 mg is used with a reduced-calorie diet and increased physical activity to help children 12 years and older with obesity to lose weight and keep the weight off
Wegovy® contains semaglutide and should not be used with other semaglutide-containing products or other GLP-1 receptor agonist medicines.
It is not known if Wegovy® injection is safe and effective:
- to reduce the risk of major cardiovascular events (death, heart attack, or stroke) in people under 18 years
- to help children under 12 years of age lose weight and keep the weight off
It is not known if Wegovy® tablets are safe and effective for use in people under 18 years of age.
What is the most important information I should know about Wegovy®?
Wegovy® may cause serious side effects, including:
- Possible thyroid tumors, including cancer. Tell your healthcare provider if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. These may be symptoms of thyroid cancer. In studies with rodents, Wegovy® and other medicines that work like Wegovy® caused thyroid tumors, including thyroid cancer. It is not known if Wegovy® will cause thyroid tumors or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in people
- Do not use Wegovy® if you or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC) or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
Important Safety Information
What is the most important information I should know about Wegovy®?
Wegovy® may cause serious side effects, including:
- Possible thyroid tumors, including cancer. Tell your healthcare provider if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. These may be symptoms of thyroid cancer. In studies with rodents, Wegovy® and other medicines that work like Wegovy® caused thyroid tumors, including thyroid cancer. It is not known if Wegovy® will cause thyroid tumors or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in people
- Do not use Wegovy® if you or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC) or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
Do not use Wegovy® if:
- you or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC) or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
- you have had a serious allergic reaction to semaglutide or any of the ingredients in Wegovy® injection or Wegovy® tablets. See symptoms of serious allergic reaction in “What are the possible side effects of Wegovy®?”
Before using Wegovy®, tell your healthcare provider if you have any other medical conditions, including if you:
- have or have had problems with your pancreas or kidneys
- have type 2 diabetes and a history of diabetic retinopathy
- have or have had depression, suicidal thoughts, or mental health issues
- are scheduled to have surgery or other procedures that use anesthesia or deep sleepiness (deep sedation)
- are pregnant or plan to become pregnant. Wegovy® may harm your unborn baby. You should stop using Wegovy® 2 months before you plan to become pregnant
- are breastfeeding or plan to breastfeed. Breastfeeding is not recommended during treatment with Wegovy® tablets. It is not known if Wegovy® when received through an injection passes into your breast milk
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Wegovy® may affect the way some medicines work and some medicines may affect the way Wegovy® works. Tell your healthcare provider if you are taking other medicines to treat diabetes, including sulfonylureas or insulin. Wegovy® slows stomach emptying and can affect medicines that need to pass through the stomach quickly.
What are the possible side effects of Wegovy®?
Wegovy® may cause serious side effects, including:
- inflammation of your pancreas (pancreatitis). Stop using Wegovy® and call your healthcare provider right away if you have severe pain in your stomach area (abdomen) that will not go away, with or without nausea or vomiting. Sometimes you may feel the pain from your abdomen to your back
- gallbladder problems. Wegovy® may cause gallbladder problems, including gallstones. Some gallstones may need surgery. Call your healthcare provider if you have symptoms, such as pain in your upper stomach (abdomen), fever, yellowing of the skin or eyes (jaundice), or clay-colored stools
- increased risk of low blood sugar (hypoglycemia), especially those who also take medicines for diabetes such as insulin or sulfonylureas. This can be a serious side effect. Talk to your healthcare provider about how to recognize and treat low blood sugar and check your blood sugar before you start and while you take Wegovy®. Signs and symptoms of low blood sugar may include dizziness or light-headedness, blurred vision, anxiety, irritability or mood changes, sweating, slurred speech, hunger, confusion or drowsiness, shakiness, weakness, headache, fast heartbeat, or feeling jittery
- dehydration leading to kidney problems. Diarrhea, nausea, and vomiting may cause a loss of fluids (dehydration), which may cause kidney problems. It is important for you to drink fluids to help reduce your chance of dehydration. Tell your healthcare provider right away if you have nausea, vomiting, or diarrhea that does not go away
- severe stomach problems. Stomach problems, sometimes severe, have been reported in people who use Wegovy®. Tell your healthcare provider if you have stomach problems that are severe or will not go away
- serious allergic reactions. Stop using Wegovy® and get medical help right away, if you have any symptoms of a serious allergic reaction, including swelling of your face, lips, tongue, or throat; problems breathing or swallowing; severe rash or itching; fainting or feeling dizzy; or very rapid heartbeat
- change in vision in people with type 2 diabetes. Tell your healthcare provider if you have changes in vision during treatment with Wegovy®
- increased heart rate. Wegovy® can increase your heart rate while you are at rest. Tell your healthcare provider if you feel your heart racing or pounding in your chest and it lasts for several minutes
- depression or thoughts of suicide. You should pay attention to any mental changes, especially sudden changes in your mood, behaviors, thoughts, or feelings. Call your healthcare provider right away if you have any mental changes that are new, worse, or worry you
- food or liquid getting into the lungs during surgery or other procedures that use anesthesia or deep sleepiness (deep sedation). Wegovy® may increase the chance of food getting into your lungs during surgery or other procedures. Tell all your healthcare providers that you are taking Wegovy® before you are scheduled to have surgery or other procedures
The most common side effects of Wegovy® may include: nausea, diarrhea, vomiting, constipation, stomach (abdomen) pain, headache, tiredness (fatigue), upset stomach, dizziness, feeling bloated, belching, low blood sugar in people with type 2 diabetes, gas, stomach flu, heartburn, and runny nose or sore throat.
Please see Prescribing Information and Medication Guide for Wegovy®.
Wegovy® is a prescription medication.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
This site is intended for US patients only.
What is Wegovy®?
Wegovy® (semaglutide) injection 1.7 mg or 2.4 mg and Wegovy® (semaglutide) tablets 25 mg are prescription medicines used with a reduced calorie diet and increased physical activity to:
- reduce the risk of major cardiovascular events such as death, heart attack, or stroke in adults with known heart disease and with either obesity or overweight.
- help adults with obesity, or some adults with excess weight (overweight) who also have weight-related medical problems to lose weight and keep the weight off.
Wegovy® (semaglutide) injection 1.7 mg or 2.4 mg is used with a reduced-calorie diet and increased physical activity to help children 12 years and older with obesity to lose weight and keep the weight off
Wegovy® contains semaglutide and should not be used with other semaglutide-containing products or other GLP-1 receptor agonist medicines.
It is not known if Wegovy® injection is safe and effective:
- to reduce the risk of major cardiovascular events (death, heart attack, or stroke) in people under 18 years
- to help children under 12 years of age lose weight and keep the weight off
It is not known if Wegovy® tablets are safe and effective for use in people under 18 years of age.